M. Ahmadi, L. Sancey, A. Briat, L. Riou, D. Boturyn et al., In-Labeled RGD-Peptide Targeting Integrin Alpha(V) Beta(3) in a Preclinical Tumor Model, Cancer Biotherapy & Radiopharmaceuticals, vol.23, issue.6, pp.691-700, 2008.
DOI : 10.1089/cbr.2008.0528
URL : https://hal.archives-ouvertes.fr/inserm-00333439

A. Borgne-sanchez, S. Dupont, A. Langonne, L. Baux, H. Lecoeur et al., Targeted Vpr-derived peptides reach mitochondria to induce apoptosis of ??V??3-expressing endothelial cells, Cell Death and Differentiation, vol.14, issue.3, pp.422-435, 2007.
DOI : 10.1016/0009-8981(94)90055-8

D. Boturyn, J. Coll, E. Garanger, M. Favrot, and P. Dumy, Template Assembled Cyclopeptides as Multimeric System for Integrin Targeting and Endocytosis, Journal of the American Chemical Society, vol.126, issue.18, pp.5730-5739, 2004.
DOI : 10.1021/ja049926n

J. Chen, X. Xu, C. Underhill, S. Yang, L. Wang et al., Tachyplesin Activates the Classic Complement Pathway to Kill Tumor Cells, Cancer Research, vol.65, issue.11, pp.4614-4622, 2001.
DOI : 10.1158/0008-5472.CAN-04-2253

Y. Chen, X. Xu, S. Hong, J. Chen, N. Liu et al., RGD- Tachyplesin inhibits tumor growth, Cancer Res, vol.61, pp.2434-2438, 2001.

H. Ellerby, W. Arap, L. Ellerby, R. Kain, R. Andrusiak et al., Anti-cancer activity of targeted pro-apoptotic peptides, Nat Med, vol.5, pp.1032-1038, 1999.

M. Ferrari, Frontiers in cancer nanomedicine: directing mass transport through biological barriers, Trends in Biotechnology, vol.28, issue.4, pp.181-188, 2010.
DOI : 10.1016/j.tibtech.2009.12.007

S. Foillard, Z. Jin, E. Garanger, D. Boturyn, M. Favrot et al., Synthesis and Biological Characterisation of Targeted Pro-Apoptotic Peptide, ChemBioChem, vol.4, issue.14, pp.2326-2332, 2008.
DOI : 10.1002/cbic.200800327
URL : https://hal.archives-ouvertes.fr/inserm-00314521

S. Foillard, L. Sancey, J. Coll, D. Boturyn, and P. Dumy, Targeted delivery of activatable fluorescent pro-apoptotic peptide into live cells, Org. Biomol. Chem., vol.42, issue.2, pp.221-224, 2009.
DOI : 10.1039/B817251J

E. Garanger, D. Boturyn, J. Z. Dumy, P. Favrot, M. Coll et al., New Multifunctional Molecular Conjugate Vector for Targeting, Imaging, and Therapy of Tumors, Molecular Therapy, vol.12, issue.6, pp.1168-1175, 2005.
DOI : 10.1016/j.ymthe.2005.06.095

Z. Jin, V. Josserand, S. Foillard, D. Boturyn, P. Dumy et al., In vivo optical imaging of integrin ??V-??3 in mice using multivalent or monovalent cRGD targeting vectors, Molecular Cancer, vol.6, issue.1, p.41, 2007.
DOI : 10.1186/1476-4598-6-41

U. Kedar, P. Phutane, S. Shidhaye, and V. Kadam, Advances in polymeric micelles for drug delivery and tumor targeting, Nanomedicine: Nanotechnology, Biology and Medicine, vol.6, issue.6, 2010.
DOI : 10.1016/j.nano.2010.05.005

M. Keramidas, V. Josserand, C. Righini, C. Wenk, C. Faure et al., Intraoperative near-infrared image-guided surgery for peritoneal carcinomatosis in a preclinical experimental model, British Journal of Surgery, vol.26, issue.5, pp.737-743, 2010.
DOI : 10.1002/bjs.6986

Y. Ko, C. Falcao, and V. Torchilin, and Bcl-2 Antisense Oligodeoxynucleotide G3139 for Enhanced Anticancer Therapy, Molecular Pharmaceutics, vol.6, issue.3, pp.971-977, 2009.
DOI : 10.1021/mp900006h

B. Law, L. Quinti, Y. Choi, R. Weissleder, and C. Tung, A mitochondrial targeted fusion peptide exhibits remarkable cytotoxicity, Molecular Cancer Therapeutics, vol.5, issue.8, pp.1944-1949, 2006.
DOI : 10.1158/1535-7163.MCT-05-0509

J. Mai, Z. Mi, S. Kim, B. Ng, and P. Robbins, A proapoptotic peptide for the treatment of solid tumors, Cancer Res, vol.61, pp.7709-7712, 2001.

A. Marks, M. Cooper, R. Anderson, K. Orchard, G. Hale et al., Selective Apoptotic Killing of Malignant Hemopoietic Cells by Antibody-Targeted Delivery of an Amphipathic Peptide, Cancer Research, vol.65, issue.6, pp.2373-2377, 2005.
DOI : 10.1158/0008-5472.CAN-04-2594

O. Reilly, M. Boehm, T. Shing, Y. Fukai, N. Vasios et al., Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth, Cell, vol.88, issue.2, pp.277-285, 1997.
DOI : 10.1016/S0092-8674(00)81848-6

T. Oshikiri, M. Miyamoto, K. Hiraoka, T. Shichinohe, Y. Kawarada et al., Transcriptional targeting of adenovirus vectors with the squamous cell carcinoma-specific antigen-2 promoter for selective apoptosis induction in lung cancer, Cancer Gene Therapy, vol.7, issue.9, pp.856-863, 2006.
DOI : 10.1038/sj.cgt.7700953

N. Papo, Z. Oren, U. Pag, H. Sahl, and Y. Shai, The Consequence of Sequence Alteration of an Amphipathic alpha -Helical Antimicrobial Peptide and Its Diastereomers, Journal of Biological Chemistry, vol.277, issue.37, pp.33913-33921, 2002.
DOI : 10.1074/jbc.M204928200

M. Reers, T. Smith, and L. Chen, J-aggregate formation of a carbocyanine as a quantitative fluorescent indicator of membrane potential, Biochemistry, vol.30, issue.18, pp.4480-4486, 1991.
DOI : 10.1021/bi00232a015

L. Sancey, V. Ardisson, L. Riou, M. Ahmadi, D. Marti-batlle et al., In vivo imaging of tumour angiogenesis in mice with the ??v??3 integrin-targeted tracer 99mTc-RAFT-RGD, European Journal of Nuclear Medicine and Molecular Imaging, vol.18, issue.Pt 19, pp.2037-2047, 2007.
DOI : 10.1007/s00259-007-0497-z
URL : https://hal.archives-ouvertes.fr/inserm-00176669

L. Sancey, E. Garanger, S. Foillard, G. Schoehn, A. Hurbin et al., Clustering and internalization of integrin avb3 with a tetrameric RGD-synthetic peptide, Mol Ther, vol.5, pp.837-843, 2009.

S. Smiley, M. Reers, C. Mottola-hartshorn, M. Lin, A. Chen et al., Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-1., Proceedings of the National Academy of Sciences, vol.88, issue.9, pp.3671-3675, 1991.
DOI : 10.1073/pnas.88.9.3671

R. Smolarczyk, T. Cichon, K. Graja, J. Hucz, A. Sochanik et al., Antitumor effect of RGD-4C-GG-D(KLAKLAK)2 peptide in mouse B16(F10) melanoma model, Acta Biochim Pol, vol.53, pp.801-805, 2006.